This site is not optimized for mobile devices. For the best mobile experience we suggest you download our mobile app!
Download on App Store App Store Icon App Store Google Play Store Icon Google Play

Pneumocystis jirovecii Pneumonia (PcP)

Pneumocystis jirovecii Pneumonia (PcP)

Primary Prophylaxis

Start: if CD4 count < 200 cells/μL, CD4 percentage < 14%, oral thrush or relevant concomitant immunosuppression, see Primary Prophylaxis of OIs

Stop: if CD4 count > 100 cells/μL and HIV-VL undetectable over 3 months

  Drug / Dose Comments
Negative or positive serology for toxoplasmosis

TMP-SMX
80/400 mg qd po or
160/800 mg qd po or
160/800 mg x 3/week po

In case of non-severe TMP-SMX allergy and if other therapeutic options are not available/not clinically appropriated, desensitization can be attempted * 
Negative serology for toxoplasmosis pentamidine
300 mg in 6 mL sterile water x 1 inhalation/month
Does not prevent the rare extrapulmonary
manifestations of P. jirovecii
Negative serology for toxoplasmosis dapsone
100 mg qd po
Check for G6PD-deficiency
Negative serology for
toxoplasmosis
atovaquone suspension
1500 mg qd po (with food)
 
Positive serology for toxoplasmosis dapsone
200 mg/week po
+ pyrimethamine
75 mg/week po
+ folinic acid
25-30 mg/week po
Check for G6PD-deficiency
Positive serology for toxoplasmosis atovaquone suspension
1500 mg qd po (with food)
+/- pyrimethamine
75 mg/week po
+ folinic acid
25-30 mg /week po
 

* for protocols see: J. Allerg. Clin. Immunol 1994; 93:1001-1005; J Infect Dis 2001 Oct 15;184(8):992-7

Diagnosis and treatment

Diagnosis:
Definitive diagnosis: Cough and dyspnea on exertion AND microorganism identification by cytology / histopathology of induced sputum (sensitivity up to 80%), broncho-alveolar lavage (sensitivity > 95%) or bronchoscopic tissue biopsy (sensitivity > 95%)

Presumptive diagnosis: CD4 count < 200 cells/μL AND dyspnea / desaturation on exertion and cough AND radiology compatible with PcP AND no evidence for bacterial pneumonia AND response to PcP treatment. SARS-CoV-2 pneumonia can resemble PcP and should therefore be included in the differential diagnoses.

Notes on treatment:
treat at least 21 days, then secondary prophylaxis until CD4 count > 100 cells/μL and HIV-VL undetectable over 3 months. See also Anti-infective/ART interaction table for treatment optimization

  Drug / Dose Comments
Preferred therapy

TMP-SMX
5 mg/kg tid TMP iv/po
+ 25 mg/kg tid SMX iv/po

Monitor myelotoxicity (mainly neutropenia), kidney function and electrolytes (mainly high potassium)

+ prednisone
40 mg bid po 5 days
40 mg qd po 5 days
20 mg qd po 10 days
if PaO2 < 10 kPa or < 70 mmHg or alveolar/arterial O2 gradient > 35 mmHg. Start prednisone preferentially 15-30 min before TMP/SMX

Benefit of corticosteroids if started within 72 hours after start of treatment
Alternative therapy for moderate to severe PcP primaquine
30 mg (base) qd po
Check for G6PD deficiency
+ clindamycin
600-900 mg tid iv/po
 
OR
pentamidine
4 mg/kg qd iv (infused over 60 min.)
 

For each regimen:
+ prednisone
40 mg bid po 5 days
40 mg qd po 5 days
20 mg qd po 10 days
if PaO2 < 10 kPa or < 70 mmHg or alveolar/arterial O2 gradient > 35 mmHg. Start prednisone preferentially 15-30 min before TMP/SMX

 

Benefit of corticosteroids if started within 72 hours after start of treatment

 

Some studies support the addition of caspofungin or other echinocandins to standard treatment in persons with moderate-severe PcP (can be considered, but not mandatory)

Alternative therapy for mild to moderate PcP

primaquine
30 mg (base) qd po

Check for G6PD deficiency

+ clindamycin
600-900 mg tid po

OR
atovaquone suspension
750 mg bid po (with food)
 

OR
dapsone

100 mg qd po

Check for G6PD deficiency.

In case of rash: reduce dose of TMP (50%), antihistamines

+ trimethoprim
5 mg/kg tid po

Secondary Prophylaxis / Maintenance Therapy

Stop: if CD4 count > 100 cells/μL and HIV-VL undetectable over 3 months

  Drug / Dose Comments
Negative or positive serology for
toxoplasmosis
TMP-SMX
400/80 mg qd po or
160/800 mg x 3/week po
 
Negative serology for toxoplasmosis pentamidine
300 mg in 6 mL sterile water x 1 inhalation/month
Not to use in the rare case of extrapulmonary manifestations of P. jirovecii
Negative serology for toxoplasmosis dapsone
100 mg qd po
Check for G6PD-deficiency
Negative serology for toxoplasmosis atovaquone suspension
1500 mg qd po (with food)
 
Positive serology for toxoplasmosis dapsone
200 mg/week po
+ pyrimethamine
75 mg/week po
+ folinic acid
25-30 mg/week po
Check for G6PD-deficiency
Positive serology for toxoplasmosis atovaquone suspension
1500 mg qd po (with food)
+/- pyrimethamine
75 mg/week po
+ folinic acid
25-30 mg/week po